Powered by

Intrexon Announces Presentations at Upcoming Investor Conferences

Jan 02, 2019 - PR Newswire
Event Announcements

PR Newswire

 Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that the company and its subsidiaries will present at upcoming investor conferences in San Francisco.

Pieter Rottiers, PhD, Chief Executive Officer of ActoBio Therapeutics, will present at the Biotech Showcase on January 8th, 2019 at 9:00 AM PT at the Hilton San Francisco Union Square. Thomas D. Reed, ...